New US subgroup data for German pharma major Boehringer Ingelheim’s Jascayd (nerandomilast) in idiopathic and progressive ...

AstraZeneca and Daiichi Sankyo have secured US approval for Datroway (datopotamab deruxtecan-dlnk) as a first-line treatment ...

Privately-held UK based AMR Bio has announced its launch as a clinical phase biotechnology company focused on one of the most ...

US pharma major Eli Lilly, the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive top-line ...

Infex Therapeutics, a UK anti-infectives specialist, today announced positive results from its Phase IIa dose-ranging study ...

The New Drug Application (NDA) for the combination of Elunate (fruquintinib) and TYVYT (sintilimab injection) has been ...

Genesis Molecular AI and Incyte announced a new kind of deal, with Incyte’s proprietary experimental data powering ...

American States are rolling out complex drug price-setting efforts - but there is no evidence yet that patients are or will ...

Scenic Biotech has progressed enormously since it was founded in 2017 as a spin-out from the Netherlands Cancer Institute and ...

Italian drugmaker Recordati reported first-quarter 2026 revenue of 713 million euros ($775 million) on Tuesday, up 5% year-on ...

Schizophrenia is a persistent and disabling mental illness that can impact all aspects of an individual’s life, including ...

Bristol Myers Squibb’s Eliquis (apixaban) is on course for one of the largest single-asset revenue collapses in ...